An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Identifieur interne : 002784 ( PubMed/Curation ); précédent : 002783; suivant : 002785An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Auteurs : Aryeh Fischer [États-Unis] ; Katerina M. Antoniou [Grèce] ; Kevin K. Brown [États-Unis] ; Jacques Cadranel [France] ; Tamera J. Corte ; Roland M. Du Bois [Royaume-Uni] ; Joyce S. Lee ; Kevin O. Leslie [États-Unis] ; David A. Lynch [États-Unis] ; Eric L. Matteson [États-Unis] ; Marta Mosca [Italie] ; Imre Noth [États-Unis] ; Luca Richeldi [Royaume-Uni] ; Mary E. Strek ; Jeffrey J. Swigris ; Athol U. Wells [Royaume-Uni] ; Sterling G. West [États-Unis] ; Harold R. Collard ; Vincent CottinSource :
- The European respiratory journal [ 1399-3003 ] ; 2015.
Descripteurs français
- KwdFr :
- Auto-immunité, Autoanticorps (), Europe, Humains, Maladies auto-immunes (), Maladies auto-immunes (diagnostic), Maladies du tissu conjonctif (immunologie), Pneumologie (normes), Pneumopathies interstitielles (), Pneumopathies interstitielles (diagnostic), Pneumopathies interstitielles (immunologie), Pneumopathies interstitielles idiopathiques (), Pneumopathies interstitielles idiopathiques (diagnostic), Pneumopathies interstitielles idiopathiques (immunologie), Sociétés médicales, États-Unis d'Amérique, Études prospectives.
- MESH :
- diagnostic : Maladies auto-immunes, Pneumopathies interstitielles, Pneumopathies interstitielles idiopathiques.
- immunologie : Maladies du tissu conjonctif, Pneumopathies interstitielles, Pneumopathies interstitielles idiopathiques.
- normes : Pneumologie.
- Auto-immunité, Autoanticorps, Europe, Humains, Maladies auto-immunes, Pneumopathies interstitielles, Pneumopathies interstitielles idiopathiques, Sociétés médicales, États-Unis d'Amérique, Études prospectives.
- Wicri :
- geographic : États-Unis.
English descriptors
- KwdEn :
- Autoantibodies (chemistry), Autoimmune Diseases (diagnosis), Autoimmune Diseases (therapy), Autoimmunity, Connective Tissue Diseases (immunology), Europe, Humans, Idiopathic Interstitial Pneumonias (diagnosis), Idiopathic Interstitial Pneumonias (immunology), Idiopathic Interstitial Pneumonias (therapy), Lung Diseases, Interstitial (diagnosis), Lung Diseases, Interstitial (immunology), Lung Diseases, Interstitial (therapy), Prospective Studies, Pulmonary Medicine (standards), Societies, Medical, United States.
- MESH :
- chemical , chemistry : Autoantibodies.
- geographic : Europe, United States.
- diagnosis : Autoimmune Diseases, Idiopathic Interstitial Pneumonias, Lung Diseases, Interstitial.
- immunology : Connective Tissue Diseases, Idiopathic Interstitial Pneumonias, Lung Diseases, Interstitial.
- standards : Pulmonary Medicine.
- therapy : Autoimmune Diseases, Idiopathic Interstitial Pneumonias, Lung Diseases, Interstitial.
- Autoimmunity, Humans, Prospective Studies, Societies, Medical.
Abstract
Many patients with an idiopathic interstitial pneumonia (IIP) have clinical features that suggest an underlying autoimmune process but do not meet established criteria for a connective tissue disease (CTD). Researchers have proposed differing criteria and terms to describe these patients, and lack of consensus over nomenclature and classification limits the ability to conduct prospective studies of a uniform cohort.The "European Respiratory Society/American Thoracic Society Task Force on Undifferentiated Forms of Connective Tissue Disease-associated Interstitial Lung Disease" was formed to create consensus regarding the nomenclature and classification criteria for patients with IIP and features of autoimmunity.The task force proposes the term "interstitial pneumonia with autoimmune features" (IPAF) and offers classification criteria organised around the presence of a combination of features from three domains: a clinical domain consisting of specific extra-thoracic features, a serologic domain consisting of specific autoantibodies, and a morphologic domain consisting of specific chest imaging, histopathologic or pulmonary physiologic features.A designation of IPAF should be used to identify individuals with IIP and features suggestive of, but not definitive for, a CTD. With IPAF, a sound platform has been provided from which to launch the requisite future research investigations of a more uniform cohort.
DOI: 10.1183/13993003.00150-2015
PubMed: 26160873
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002853
Links to Exploration step
pubmed:26160873Curation
No country items
Tamera J. Corte<affiliation><nlm:affiliation>The Aldred Hospital, Melbourne, Australia Members of the writing group of the task force.</nlm:affiliation><wicri:noCountry code="subField">Australia Members of the writing group of the task force</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Medicine, University of California San Francisco, San Francisco, CA, USA Members of the writing group of the task force.</nlm:affiliation><wicri:noCountry code="subField">USA Members of the writing group of the task force</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Medicine, University of Chicago, Chicago, IL, USA Members of the writing group of the task force.</nlm:affiliation><wicri:noCountry code="subField">USA Members of the writing group of the task force</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Dept of Medicine, National Jewish Health, Denver, CO, USA Members of the writing group of the task force.</nlm:affiliation><wicri:noCountry code="subField">USA Members of the writing group of the task force</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Medicine, University of California San Francisco, San Francisco, CA, USA Members of the writing group of the task force Task force vice-chairs, and contributed equally to this manuscript.</nlm:affiliation><wicri:noCountry code="subField">and contributed equally to this manuscript</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Service de Pneumologie, Hopital L. Pradel, Lyon, France Members of the writing group of the task force Task force vice-chairs, and contributed equally to this manuscript.</nlm:affiliation><wicri:noCountry code="subField">and contributed equally to this manuscript</wicri:noCountry></affiliation>Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.</title><author><name sortKey="Fischer, Aryeh" sort="Fischer, Aryeh" uniqKey="Fischer A" first="Aryeh" last="Fischer">Aryeh Fischer</name><affiliation wicri:level="1"><nlm:affiliation>Dept of Medicine, University of Colorado School of Medicine, Denver, CO, USA Task force chair Members of the writing group of the task force aryeh.fischer@ucdenver.edu.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Dept of Medicine, University of Colorado School of Medicine, Denver, CO</wicri:regionArea></affiliation></author><author><name sortKey="Antoniou, Katerina M" sort="Antoniou, Katerina M" uniqKey="Antoniou K" first="Katerina M" last="Antoniou">Katerina M. Antoniou</name><affiliation wicri:level="1"><nlm:affiliation>Thoracic Medicine, University of Crete, Heraklion, Greece.</nlm:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Thoracic Medicine, University of Crete, Heraklion</wicri:regionArea></affiliation></author><author><name sortKey="Brown, Kevin K" sort="Brown, Kevin K" uniqKey="Brown K" first="Kevin K" last="Brown">Kevin K. Brown</name><affiliation wicri:level="1"><nlm:affiliation>Dept of Medicine, National Jewish Health, Denver, CO, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Dept of Medicine, National Jewish Health, Denver, CO</wicri:regionArea></affiliation></author><author><name sortKey="Cadranel, Jacques" sort="Cadranel, Jacques" uniqKey="Cadranel J" first="Jacques" last="Cadranel">Jacques Cadranel</name><affiliation wicri:level="1"><nlm:affiliation>Pneumologie, Hopital Tenon, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pneumologie, Hopital Tenon, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Corte, Tamera J" sort="Corte, Tamera J" uniqKey="Corte T" first="Tamera J" last="Corte">Tamera J. Corte</name><affiliation><nlm:affiliation>The Aldred Hospital, Melbourne, Australia Members of the writing group of the task force.</nlm:affiliation><wicri:noCountry code="subField">Australia Members of the writing group of the task force</wicri:noCountry></affiliation></author><author><name sortKey="Du Bois, Roland M" sort="Du Bois, Roland M" uniqKey="Du Bois R" first="Roland M" last="Du Bois">Roland M. Du Bois</name><affiliation wicri:level="1"><nlm:affiliation>Interstitial Lung Disease Unit, Dept of Occupational Medicine, Royal Brompton Hospital, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Interstitial Lung Disease Unit, Dept of Occupational Medicine, Royal Brompton Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="Lee, Joyce S" sort="Lee, Joyce S" uniqKey="Lee J" first="Joyce S" last="Lee">Joyce S. Lee</name><affiliation><nlm:affiliation>Medicine, University of California San Francisco, San Francisco, CA, USA Members of the writing group of the task force.</nlm:affiliation><wicri:noCountry code="subField">USA Members of the writing group of the task force</wicri:noCountry></affiliation></author><author><name sortKey="Leslie, Kevin O" sort="Leslie, Kevin O" uniqKey="Leslie K" first="Kevin O" last="Leslie">Kevin O. Leslie</name><affiliation wicri:level="1"><nlm:affiliation>Pathology, Mayo Clinic, Scottsdale, AZ, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pathology, Mayo Clinic, Scottsdale, AZ</wicri:regionArea></affiliation></author><author><name sortKey="Lynch, David A" sort="Lynch, David A" uniqKey="Lynch D" first="David A" last="Lynch">David A. Lynch</name><affiliation wicri:level="1"><nlm:affiliation>Dept of Radiology, National Jewish Health, Denver, CO, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Dept of Radiology, National Jewish Health, Denver, CO</wicri:regionArea></affiliation></author><author><name sortKey="Matteson, Eric L" sort="Matteson, Eric L" uniqKey="Matteson E" first="Eric L" last="Matteson">Eric L. Matteson</name><affiliation wicri:level="1"><nlm:affiliation>Division of Rheumatology, Mayo College of Medicine, Rochester, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Mayo College of Medicine, Rochester, MN</wicri:regionArea></affiliation></author><author><name sortKey="Mosca, Marta" sort="Mosca, Marta" uniqKey="Mosca M" first="Marta" last="Mosca">Marta Mosca</name><affiliation wicri:level="1"><nlm:affiliation>University of Pisa, Pisa, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>University of Pisa, Pisa</wicri:regionArea></affiliation></author><author><name sortKey="Noth, Imre" sort="Noth, Imre" uniqKey="Noth I" first="Imre" last="Noth">Imre Noth</name><affiliation wicri:level="1"><nlm:affiliation>Medicine, University of Chicago, Chicago, IL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Medicine, University of Chicago, Chicago, IL</wicri:regionArea></affiliation></author><author><name sortKey="Richeldi, Luca" sort="Richeldi, Luca" uniqKey="Richeldi L" first="Luca" last="Richeldi">Luca Richeldi</name><affiliation wicri:level="1"><nlm:affiliation>Southampton General Hospital, Southampton, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Southampton General Hospital, Southampton</wicri:regionArea></affiliation></author><author><name sortKey="Strek, Mary E" sort="Strek, Mary E" uniqKey="Strek M" first="Mary E" last="Strek">Mary E. Strek</name><affiliation><nlm:affiliation>Medicine, University of Chicago, Chicago, IL, USA Members of the writing group of the task force.</nlm:affiliation><wicri:noCountry code="subField">USA Members of the writing group of the task force</wicri:noCountry></affiliation></author><author><name sortKey="Swigris, Jeffrey J" sort="Swigris, Jeffrey J" uniqKey="Swigris J" first="Jeffrey J" last="Swigris">Jeffrey J. Swigris</name><affiliation><nlm:affiliation>Dept of Medicine, National Jewish Health, Denver, CO, USA Members of the writing group of the task force.</nlm:affiliation><wicri:noCountry code="subField">USA Members of the writing group of the task force</wicri:noCountry></affiliation></author><author><name sortKey="Wells, Athol U" sort="Wells, Athol U" uniqKey="Wells A" first="Athol U" last="Wells">Athol U. Wells</name><affiliation wicri:level="1"><nlm:affiliation>Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Interstitial Lung Disease Unit, Royal Brompton Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="West, Sterling G" sort="West, Sterling G" uniqKey="West S" first="Sterling G" last="West">Sterling G. West</name><affiliation wicri:level="1"><nlm:affiliation>University of Colorado School of Medicine, Aurora, CO, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of Colorado School of Medicine, Aurora, CO</wicri:regionArea></affiliation></author><author><name sortKey="Collard, Harold R" sort="Collard, Harold R" uniqKey="Collard H" first="Harold R" last="Collard">Harold R. Collard</name><affiliation><nlm:affiliation>Medicine, University of California San Francisco, San Francisco, CA, USA Members of the writing group of the task force Task force vice-chairs, and contributed equally to this manuscript.</nlm:affiliation><wicri:noCountry code="subField">and contributed equally to this manuscript</wicri:noCountry></affiliation></author><author><name sortKey="Cottin, Vincent" sort="Cottin, Vincent" uniqKey="Cottin V" first="Vincent" last="Cottin">Vincent Cottin</name><affiliation><nlm:affiliation>Service de Pneumologie, Hopital L. Pradel, Lyon, France Members of the writing group of the task force Task force vice-chairs, and contributed equally to this manuscript.</nlm:affiliation><wicri:noCountry code="subField">and contributed equally to this manuscript</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26160873</idno><idno type="pmid">26160873</idno><idno type="doi">10.1183/13993003.00150-2015</idno><idno type="wicri:Area/PubMed/Corpus">002853</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002853</idno><idno type="wicri:Area/PubMed/Curation">002784</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002784</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.</title><author><name sortKey="Fischer, Aryeh" sort="Fischer, Aryeh" uniqKey="Fischer A" first="Aryeh" last="Fischer">Aryeh Fischer</name><affiliation wicri:level="1"><nlm:affiliation>Dept of Medicine, University of Colorado School of Medicine, Denver, CO, USA Task force chair Members of the writing group of the task force aryeh.fischer@ucdenver.edu.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Dept of Medicine, University of Colorado School of Medicine, Denver, CO</wicri:regionArea></affiliation></author><author><name sortKey="Antoniou, Katerina M" sort="Antoniou, Katerina M" uniqKey="Antoniou K" first="Katerina M" last="Antoniou">Katerina M. Antoniou</name><affiliation wicri:level="1"><nlm:affiliation>Thoracic Medicine, University of Crete, Heraklion, Greece.</nlm:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Thoracic Medicine, University of Crete, Heraklion</wicri:regionArea></affiliation></author><author><name sortKey="Brown, Kevin K" sort="Brown, Kevin K" uniqKey="Brown K" first="Kevin K" last="Brown">Kevin K. Brown</name><affiliation wicri:level="1"><nlm:affiliation>Dept of Medicine, National Jewish Health, Denver, CO, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Dept of Medicine, National Jewish Health, Denver, CO</wicri:regionArea></affiliation></author><author><name sortKey="Cadranel, Jacques" sort="Cadranel, Jacques" uniqKey="Cadranel J" first="Jacques" last="Cadranel">Jacques Cadranel</name><affiliation wicri:level="1"><nlm:affiliation>Pneumologie, Hopital Tenon, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pneumologie, Hopital Tenon, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Corte, Tamera J" sort="Corte, Tamera J" uniqKey="Corte T" first="Tamera J" last="Corte">Tamera J. Corte</name><affiliation><nlm:affiliation>The Aldred Hospital, Melbourne, Australia Members of the writing group of the task force.</nlm:affiliation><wicri:noCountry code="subField">Australia Members of the writing group of the task force</wicri:noCountry></affiliation></author><author><name sortKey="Du Bois, Roland M" sort="Du Bois, Roland M" uniqKey="Du Bois R" first="Roland M" last="Du Bois">Roland M. Du Bois</name><affiliation wicri:level="1"><nlm:affiliation>Interstitial Lung Disease Unit, Dept of Occupational Medicine, Royal Brompton Hospital, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Interstitial Lung Disease Unit, Dept of Occupational Medicine, Royal Brompton Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="Lee, Joyce S" sort="Lee, Joyce S" uniqKey="Lee J" first="Joyce S" last="Lee">Joyce S. Lee</name><affiliation><nlm:affiliation>Medicine, University of California San Francisco, San Francisco, CA, USA Members of the writing group of the task force.</nlm:affiliation><wicri:noCountry code="subField">USA Members of the writing group of the task force</wicri:noCountry></affiliation></author><author><name sortKey="Leslie, Kevin O" sort="Leslie, Kevin O" uniqKey="Leslie K" first="Kevin O" last="Leslie">Kevin O. Leslie</name><affiliation wicri:level="1"><nlm:affiliation>Pathology, Mayo Clinic, Scottsdale, AZ, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pathology, Mayo Clinic, Scottsdale, AZ</wicri:regionArea></affiliation></author><author><name sortKey="Lynch, David A" sort="Lynch, David A" uniqKey="Lynch D" first="David A" last="Lynch">David A. Lynch</name><affiliation wicri:level="1"><nlm:affiliation>Dept of Radiology, National Jewish Health, Denver, CO, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Dept of Radiology, National Jewish Health, Denver, CO</wicri:regionArea></affiliation></author><author><name sortKey="Matteson, Eric L" sort="Matteson, Eric L" uniqKey="Matteson E" first="Eric L" last="Matteson">Eric L. Matteson</name><affiliation wicri:level="1"><nlm:affiliation>Division of Rheumatology, Mayo College of Medicine, Rochester, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Mayo College of Medicine, Rochester, MN</wicri:regionArea></affiliation></author><author><name sortKey="Mosca, Marta" sort="Mosca, Marta" uniqKey="Mosca M" first="Marta" last="Mosca">Marta Mosca</name><affiliation wicri:level="1"><nlm:affiliation>University of Pisa, Pisa, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>University of Pisa, Pisa</wicri:regionArea></affiliation></author><author><name sortKey="Noth, Imre" sort="Noth, Imre" uniqKey="Noth I" first="Imre" last="Noth">Imre Noth</name><affiliation wicri:level="1"><nlm:affiliation>Medicine, University of Chicago, Chicago, IL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Medicine, University of Chicago, Chicago, IL</wicri:regionArea></affiliation></author><author><name sortKey="Richeldi, Luca" sort="Richeldi, Luca" uniqKey="Richeldi L" first="Luca" last="Richeldi">Luca Richeldi</name><affiliation wicri:level="1"><nlm:affiliation>Southampton General Hospital, Southampton, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Southampton General Hospital, Southampton</wicri:regionArea></affiliation></author><author><name sortKey="Strek, Mary E" sort="Strek, Mary E" uniqKey="Strek M" first="Mary E" last="Strek">Mary E. Strek</name><affiliation><nlm:affiliation>Medicine, University of Chicago, Chicago, IL, USA Members of the writing group of the task force.</nlm:affiliation><wicri:noCountry code="subField">USA Members of the writing group of the task force</wicri:noCountry></affiliation></author><author><name sortKey="Swigris, Jeffrey J" sort="Swigris, Jeffrey J" uniqKey="Swigris J" first="Jeffrey J" last="Swigris">Jeffrey J. Swigris</name><affiliation><nlm:affiliation>Dept of Medicine, National Jewish Health, Denver, CO, USA Members of the writing group of the task force.</nlm:affiliation><wicri:noCountry code="subField">USA Members of the writing group of the task force</wicri:noCountry></affiliation></author><author><name sortKey="Wells, Athol U" sort="Wells, Athol U" uniqKey="Wells A" first="Athol U" last="Wells">Athol U. Wells</name><affiliation wicri:level="1"><nlm:affiliation>Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Interstitial Lung Disease Unit, Royal Brompton Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="West, Sterling G" sort="West, Sterling G" uniqKey="West S" first="Sterling G" last="West">Sterling G. West</name><affiliation wicri:level="1"><nlm:affiliation>University of Colorado School of Medicine, Aurora, CO, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of Colorado School of Medicine, Aurora, CO</wicri:regionArea></affiliation></author><author><name sortKey="Collard, Harold R" sort="Collard, Harold R" uniqKey="Collard H" first="Harold R" last="Collard">Harold R. Collard</name><affiliation><nlm:affiliation>Medicine, University of California San Francisco, San Francisco, CA, USA Members of the writing group of the task force Task force vice-chairs, and contributed equally to this manuscript.</nlm:affiliation><wicri:noCountry code="subField">and contributed equally to this manuscript</wicri:noCountry></affiliation></author><author><name sortKey="Cottin, Vincent" sort="Cottin, Vincent" uniqKey="Cottin V" first="Vincent" last="Cottin">Vincent Cottin</name><affiliation><nlm:affiliation>Service de Pneumologie, Hopital L. Pradel, Lyon, France Members of the writing group of the task force Task force vice-chairs, and contributed equally to this manuscript.</nlm:affiliation><wicri:noCountry code="subField">and contributed equally to this manuscript</wicri:noCountry></affiliation></author></analytic><series><title level="j">The European respiratory journal</title><idno type="eISSN">1399-3003</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Autoantibodies (chemistry)</term><term>Autoimmune Diseases (diagnosis)</term><term>Autoimmune Diseases (therapy)</term><term>Autoimmunity</term><term>Connective Tissue Diseases (immunology)</term><term>Europe</term><term>Humans</term><term>Idiopathic Interstitial Pneumonias (diagnosis)</term><term>Idiopathic Interstitial Pneumonias (immunology)</term><term>Idiopathic Interstitial Pneumonias (therapy)</term><term>Lung Diseases, Interstitial (diagnosis)</term><term>Lung Diseases, Interstitial (immunology)</term><term>Lung Diseases, Interstitial (therapy)</term><term>Prospective Studies</term><term>Pulmonary Medicine (standards)</term><term>Societies, Medical</term><term>United States</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Auto-immunité</term><term>Autoanticorps ()</term><term>Europe</term><term>Humains</term><term>Maladies auto-immunes ()</term><term>Maladies auto-immunes (diagnostic)</term><term>Maladies du tissu conjonctif (immunologie)</term><term>Pneumologie (normes)</term><term>Pneumopathies interstitielles ()</term><term>Pneumopathies interstitielles (diagnostic)</term><term>Pneumopathies interstitielles (immunologie)</term><term>Pneumopathies interstitielles idiopathiques ()</term><term>Pneumopathies interstitielles idiopathiques (diagnostic)</term><term>Pneumopathies interstitielles idiopathiques (immunologie)</term><term>Sociétés médicales</term><term>États-Unis d'Amérique</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Autoantibodies</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Europe</term><term>United States</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Autoimmune Diseases</term><term>Idiopathic Interstitial Pneumonias</term><term>Lung Diseases, Interstitial</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Maladies auto-immunes</term><term>Pneumopathies interstitielles</term><term>Pneumopathies interstitielles idiopathiques</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Maladies du tissu conjonctif</term><term>Pneumopathies interstitielles</term><term>Pneumopathies interstitielles idiopathiques</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Connective Tissue Diseases</term><term>Idiopathic Interstitial Pneumonias</term><term>Lung Diseases, Interstitial</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Pneumologie</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Pulmonary Medicine</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Autoimmune Diseases</term><term>Idiopathic Interstitial Pneumonias</term><term>Lung Diseases, Interstitial</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Autoimmunity</term><term>Humans</term><term>Prospective Studies</term><term>Societies, Medical</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Auto-immunité</term><term>Autoanticorps</term><term>Europe</term><term>Humains</term><term>Maladies auto-immunes</term><term>Pneumopathies interstitielles</term><term>Pneumopathies interstitielles idiopathiques</term><term>Sociétés médicales</term><term>États-Unis d'Amérique</term><term>Études prospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Many patients with an idiopathic interstitial pneumonia (IIP) have clinical features that suggest an underlying autoimmune process but do not meet established criteria for a connective tissue disease (CTD). Researchers have proposed differing criteria and terms to describe these patients, and lack of consensus over nomenclature and classification limits the ability to conduct prospective studies of a uniform cohort.The "European Respiratory Society/American Thoracic Society Task Force on Undifferentiated Forms of Connective Tissue Disease-associated Interstitial Lung Disease" was formed to create consensus regarding the nomenclature and classification criteria for patients with IIP and features of autoimmunity.The task force proposes the term "interstitial pneumonia with autoimmune features" (IPAF) and offers classification criteria organised around the presence of a combination of features from three domains: a clinical domain consisting of specific extra-thoracic features, a serologic domain consisting of specific autoantibodies, and a morphologic domain consisting of specific chest imaging, histopathologic or pulmonary physiologic features.A designation of IPAF should be used to identify individuals with IIP and features suggestive of, but not definitive for, a CTD. With IPAF, a sound platform has been provided from which to launch the requisite future research investigations of a more uniform cohort.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26160873</PMID><DateCreated><Year>2015</Year><Month>10</Month><Day>01</Day></DateCreated><DateCompleted><Year>2016</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2015</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-3003</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The European respiratory journal</Title><ISOAbbreviation>Eur. Respir. J.</ISOAbbreviation></Journal><ArticleTitle>An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.</ArticleTitle><Pagination><MedlinePgn>976-87</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1183/13993003.00150-2015</ELocationID><Abstract><AbstractText>Many patients with an idiopathic interstitial pneumonia (IIP) have clinical features that suggest an underlying autoimmune process but do not meet established criteria for a connective tissue disease (CTD). Researchers have proposed differing criteria and terms to describe these patients, and lack of consensus over nomenclature and classification limits the ability to conduct prospective studies of a uniform cohort.The "European Respiratory Society/American Thoracic Society Task Force on Undifferentiated Forms of Connective Tissue Disease-associated Interstitial Lung Disease" was formed to create consensus regarding the nomenclature and classification criteria for patients with IIP and features of autoimmunity.The task force proposes the term "interstitial pneumonia with autoimmune features" (IPAF) and offers classification criteria organised around the presence of a combination of features from three domains: a clinical domain consisting of specific extra-thoracic features, a serologic domain consisting of specific autoantibodies, and a morphologic domain consisting of specific chest imaging, histopathologic or pulmonary physiologic features.A designation of IPAF should be used to identify individuals with IIP and features suggestive of, but not definitive for, a CTD. With IPAF, a sound platform has been provided from which to launch the requisite future research investigations of a more uniform cohort.</AbstractText><CopyrightInformation>Copyright ©ERS 2015.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Aryeh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dept of Medicine, University of Colorado School of Medicine, Denver, CO, USA Task force chair Members of the writing group of the task force aryeh.fischer@ucdenver.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniou</LastName><ForeName>Katerina M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Thoracic Medicine, University of Crete, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Kevin K</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Dept of Medicine, National Jewish Health, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cadranel</LastName><ForeName>Jacques</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pneumologie, Hopital Tenon, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corte</LastName><ForeName>Tamera J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>The Aldred Hospital, Melbourne, Australia Members of the writing group of the task force.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>du Bois</LastName><ForeName>Roland M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Interstitial Lung Disease Unit, Dept of Occupational Medicine, Royal Brompton Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Joyce S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Medicine, University of California San Francisco, San Francisco, CA, USA Members of the writing group of the task force.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kevin O</ForeName><Initials>KO</Initials><AffiliationInfo><Affiliation>Pathology, Mayo Clinic, Scottsdale, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Dept of Radiology, National Jewish Health, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matteson</LastName><ForeName>Eric L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Mayo College of Medicine, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosca</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noth</LastName><ForeName>Imre</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Medicine, University of Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richeldi</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Southampton General Hospital, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strek</LastName><ForeName>Mary E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Medicine, University of Chicago, Chicago, IL, USA Members of the writing group of the task force.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swigris</LastName><ForeName>Jeffrey J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Dept of Medicine, National Jewish Health, Denver, CO, USA Members of the writing group of the task force.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wells</LastName><ForeName>Athol U</ForeName><Initials>AU</Initials><AffiliationInfo><Affiliation>Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>West</LastName><ForeName>Sterling G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>University of Colorado School of Medicine, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collard</LastName><ForeName>Harold R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Medicine, University of California San Francisco, San Francisco, CA, USA Members of the writing group of the task force Task force vice-chairs, and contributed equally to this manuscript.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cottin</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Service de Pneumologie, Hopital L. Pradel, Lyon, France Members of the writing group of the task force Task force vice-chairs, and contributed equally to this manuscript.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>“ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD”</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Respir J</MedlineTA><NlmUniqueID>8803460</NlmUniqueID><ISSNLinking>0903-1936</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur Respir J. 2016 Apr;47(4):1295-6</RefSource><PMID Version="1">27037323</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Eur Respir J. 2016 Apr;47(4):1293-5</RefSource><PMID Version="1">27037322</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003240" MajorTopicYN="N">Connective Tissue Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054988" MajorTopicYN="N">Idiopathic Interstitial Pneumonias</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017563" MajorTopicYN="N">Lung Diseases, Interstitial</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015272" MajorTopicYN="N">Pulmonary Medicine</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012955" MajorTopicYN="N">Societies, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>01</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>05</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26160873</ArticleId><ArticleId IdType="pii">13993003.00150-2015</ArticleId><ArticleId IdType="doi">10.1183/13993003.00150-2015</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002784 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002784 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:26160873
|texte= An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:26160873" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |